name: | Famciclovir |
ATC code: | J05AB09 | route: | oral |
n-compartments | 1 |
Famciclovir is an oral prodrug of penciclovir, an antiviral agent used primarily for the treatment of herpes zoster (shingles) and herpes simplex virus infections. It is approved for use in adults and adolescents and is widely used today.
Pharmacokinetic parameters derived from healthy adult subjects following a single oral dose of famciclovir 500 mg.
Schenkel, F, et al., & Daali, Y (2013). Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model. The Journal of antimicrobial chemotherapy 68(7) 1635–1641. DOI:10.1093/jac/dkt064 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23539240
Ogungbenro, K, et al., & Aarons, L (2009). Population pharmacokinetics and optimal design of paediatric studies for famciclovir. British journal of clinical pharmacology 68(4) 546–560. DOI:10.1111/j.1365-2125.2009.03479.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/19843058
Blumer, J, et al., & Hamed, K (2010). Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children. Antimicrobial agents and chemotherapy 54(5) 2032–2041. DOI:10.1128/AAC.01508-09 PUBMED:https://pubmed.ncbi.nlm.nih.gov/20160046